ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments

ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments

In the recent years, it was recognized that type-2 inflammation links many forms of nasal polyposis with severe asthma. Thus, some biological drugs developed for severe asthma appeared to exert an effect on nasal polyposis. So far, there are several trials supporting this concept; therefore, some mo...

Full description

Bibliographic Details
Main Authors: Carlo Lombardi, MD, Riccardo Asero, MD, Diego Bagnasco, MD, Francesco Blasi, MD, Matteo Bonini, MD, Mario Bussi, MD, Rikki F. Canevari, MD, Giorgio Walter Canonica, MD, Paolo Castelnuovo, MD, Lorenzo Cecchi, MD, Lorenzo Cosmi, MD, Matteo Gelardi, MD, Enrico Heffler, MD, Luciana Indinnimeo, MD, Massimo Landi, MD, Amelia Licari, MD, Francesco Liotta, MD, Alberto Macchi, MD, Luca Malvezzi, MD, Gianluigi Marseglia, MD, Claudio Micheletto, MD, Antonino Musarra, MD, Diego Peroni, MD, Giorgio Piacentini, MD, Venerino Poletti, MD, Luca Richeldi, MD, Angela Santoni, MD, Michele Schiappoli, MD, Gianenrico Senna, MD, Adriano Vaghi, MD, Alberto Villani, MD, Giovanni Passalacqua, MD
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:World Allergy Organization Journal
Subjects:
Nasal polyps
CRSwNP
Biological antibodies
ARIA
Personalized medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455121000867

Internet

http://www.sciencedirect.com/science/article/pii/S1939455121000867

Similar Items